Nanox International Laboratory Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2012
NCT01599169
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Nanox International Laboratory (Belgique)

Active Ingredients

Drugs in Other Trials (4)

alpha-casozepine (1 trial)

eleutherococcus senticosus (1 trial)

melon juice (1 trial)

taurine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 4